.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Dr. Norm's has shown a consistent presence in the California market, particularly in the Capsules category. Over the months from December 2025 to March 2026, the brand maintained strong rankings, holding steady at 8th place in December and January before moving up to 7th place in February and March. This upward movement in ranking is complemented by a notable increase in sales, with March 2026 sales reaching $150,794, indicating a positive trend and growing consumer interest in their capsule products. Such performance suggests that Dr. Norm's is solidifying its position in the Capsules category within the state.
In contrast, Dr. Norm's performance in the Edible category in California presents a more mixed picture. While the brand consistently remained within the top 20, its ranking fluctuated slightly, dropping to 19th in January 2026 before returning to 17th position in February and March. Despite these fluctuations, sales figures reveal a rebound in March, suggesting a recovery from the dip experienced in January. However, the absence of Dr. Norm's from the top 30 in other states or provinces indicates potential areas for growth and expansion beyond the California market.
Competitive Landscape
In the competitive landscape of the California edible cannabis market, Dr. Norm's has shown a resilient performance amidst fluctuating ranks and sales figures. While Kiva Chocolate and Big Pete's Treats have experienced a decline in their rankings, with Kiva dropping from 15th to 19th and Big Pete's Treats from 16th to 18th from December 2025 to March 2026, Dr. Norm's has maintained a relatively stable position, ranking 17th in both December 2025 and March 2026. This stability is noteworthy despite a slight dip in January 2026. In terms of sales, Dr. Norm's saw a positive rebound in March 2026, contrasting with the downward trend observed in Kiva's and Big Pete's Treats' sales. Meanwhile, Clsics improved its rank from 19th to 16th, and Zen Cannabis consistently held higher ranks, indicating a competitive pressure on Dr. Norm's to innovate and capture more market share to climb the ranks further.
Notable Products
In March 2026, Indica Max Tablets 20-Pack (1000mg) maintained its position as the top-performing product for Dr. Norm's, with sales reaching 3492. Sleep Well - THC/CBN 2:1 Elderberry Nano Sleep Gummies 10-Pack (100mg THC, 50mg CBN) made a significant leap to rank 2, showcasing a notable increase from previous months. Key Lime High Max Gummy (100mg) held steady at rank 3, despite a slight decrease in sales compared to February. Wicked Watermelon Hash Gummy (100mg) saw a drop to the fourth position, continuing its downward trend from the top spot in December. Mango Madness Max Solventless Hash Gummy (100mg) remained in the fifth position, showing a modest recovery in sales from February.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
